Dimension-adaptive delivery carrier based on DNA origami structure and application
Through the size adaptive delivery vector based on DNA origami structure, the combination of dynamic units and static control units is used to solve the problem of insufficient retention and permeability of nanodrugs in vivo, the size adjustment of DNA strands is achieved, and the delivery of nanodrugs is improved Efficiency and efficacy.
Patent Information
- Application Number
- CN202411185346.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-27
- Publication Date
- 2024-11-22
AI Technical Summary
The existing nanodrug delivery system has limited permeability and retention problems during drug delivery, resulting in large-size nanodrugs staying around tumor blood vessels but low cell uptake efficiency, while small-size nanodrugs are low in tumor environments. Influencing the efficacy.
Design a size adaptive delivery vector based on DNA origami structure. Through the combination of dynamic units and static control units, the DNA strands are contracted and expanded by using staple strands and i-motif sequences, and the size of nanostructures is adjusted, thereby improving the Retention and permeability in vivo.
By changing the pH value or adding complementary strands, dynamic changes in DNA double helix spacing are achieved, the retention and permeability of nanocarriers are improved, the elimination rate is reduced, and the effective delivery of targeted molecules and drugs to the tumor area is improved, thereby improving the therapeutic effect.
Smart Images

Figure CN118987247A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of DNA origami structures, and in particular relates to a size-adaptive delivery carrier based on a DNA origami structure and its application. Background Art
[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.
[0003] Nano drug delivery systems, thanks to their high synthesis efficiency, high specific surface area, and ease of modification, can integrate multiple functional components to prepare precisely targeted, long-circulating, safe and efficient composite nano drugs, which have broad application prospects in the field of anti-tumor. Studies have shown that the size of nanoparticles affects their transport in the body in three main ways: (1) the size effect of delivery through different routes of administration; (2) the size effect on various tissues / organs; (3) the size effect of elimination from clearance organs. These three aspects represent the complete journey of nanoparticles in the body from delivery to positioning and final clearance. However, more and more studies have found that simply delivering nano drugs to the target site is far from enough, and accumulation and penetration problems still largely affect the efficacy of nano drug delivery.
[0004] During drug delivery, there are many challenges to the expected anti-tumor effect of nanomedicines due to limited permeability and retention. One of the typical drug delivery paradoxes is that large-sized nanomedicines can stay around tumor blood vessels for a long time, but their cellular uptake efficiency is limited; in contrast, smaller-sized nanomedicines have higher cellular uptake efficiency, but high clearance rates and low retention rates in the tumor environment.
[0005] Therefore, it is necessary to design a stimulus-induced contractile and extendable DNA nanodelivery system to solve the above problems. Summary of the invention
[0006] The purpose of the present invention is to provide a size-adaptive delivery vector based on DNA origami structure, which can adjust its size by coupling DNA chains, thereby changing its retention and permeability in the body.
[0007] To achieve the above objectives, in the first aspect, the present invention provides a size-adaptive delivery vector based on a DNA origami structure, comprising a single-layer DNA origami structure, wherein the single-layer DNA origami structure is divided into a dynamic unit and a static control unit, wherein the dynamic unit scaffold DNA is wired in a zigzag manner, and adjacent DNA helices are connected to each other with 42-nt single strands at both ends, and adjacent DNA helices are cross-linked by staple chains, and targeting molecules or drug molecules are connected to DNA and grafted to the DNA nanostructure carrier with complementary DNA sequences to achieve nanodrug delivery.
[0008] As a further improvement of the present invention, the single-layer DNA origami body of the present invention is composed of 32 double helices (HB), all the Holiday cross-connection units in the upper 16HB are replaced by dynamic units, and the Holiday cross-connection design in the lower 16HB is used as a static control unit.
[0009] As a further improvement of the present invention, the staple chain sequence design is based on the sequence of the upper 16HB of the single-layer DNA origami body, the total number of sites where the staple chain connects each adjacent DNA helix is 5 or 6, and the self-complementary sequences of the staple chain are 25-nt i-motif and DNA hairpin. Preferably, the 25-nt i-motif nucleotide sequence is as shown in SEQ ID NO.1, and the DNA hairpin nucleotide sequence is as shown in SEQ ID NO.2:
[0010] 25-nt i-motif:-AACCC,TAACCC,TAACCC,TAACCCAA-(SEQ ID NO.1);
[0011] DNA hairpin: -TGCGACCGTTTTTTTTACGGTCGCT- (SEQ ID NO. 2).
[0012] In the contracted state, the static structural unit links the adjacent DNA double helices by the Holiday cross structure, and the dynamic structural part, formed by the dynamic trigger unit in the contracted state, forms an intramolecular secondary structure, acting as a joint to connect the adjacent DNA double helices. When the dynamic trigger unit hybridizes with their respective complementary chains, the secondary structure of the dynamic trigger unit is opened and extended to the double helix, thereby expanding the distance between adjacent double helices.
[0013] As a further improvement of the present invention, the main body width of the single-layer DNA origami structure is 51 nm, and the length size range of the dynamic unit is 40.5 nm to 157.5 nm.
[0014] like Figure 1As shown, in the contracted state, these dynamic units act as protruding joints to connect parallel duplexes. When hybridized with their respective complementary strands, the secondary structure is opened and extended to the duplex, thereby expanding the distance between the duplex-duplex strands. Compared with the 2.7nm duplex spacing characterized in DNA origami, the fully extended duplex spacing with dynamic crossovers should be 8.5nm (25 base pairs). The present invention has 16 adjacent duplexes connected by DNA strands containing dynamic units, so full expansion can expand the structure length from 40.5nm to 157.5nm.
[0015] The size-adaptive delivery carrier based on DNA origami structure designed in the present invention can deliver a shrunk small carrier with targeting molecules and drug payload to the tumor area and expand its size to minimize the elimination rate. This dynamically expanding and contracting nanostructure has great application potential in both optics and biochemistry.
[0016] In a second aspect, the present invention provides a method for preparing a size-adaptive delivery vector based on a DNA origami structure, comprising the following steps:
[0017] S1: Preparation of single-layer DNA origami;
[0018] S2: Purification of the monolayer DNA origami in S1;
[0019] S3: Assemble the telescopic complementary chain F with the sample in S2 to achieve the extension of the DNA origami structure;
[0020] S4: Adding the fuel chain F' can replace the telescopic complementary chain F and achieve the contraction of the DNA origami structure.
[0021] As a further improvement of the present invention, in S1, the skeleton chain and the staple chain are mixed uniformly in proportion, and in 1×TAE, 10mMMg 2+ An annealing reaction is carried out in a solution to obtain a mixed solution containing a target monolayer DNA origami and excess stapler chains, wherein the backbone chain is a mini-M13 scaffold DNA, and the stapler chains are a 25-nt i-motif and a DNA hairpin structure.
[0022] The backbone chain of the present invention adopts mini-M13 scaffold DNA to construct a DNA origami structure that can be unfolded and folded to change size. The distance between the DNA double helices is adjusted by changing the pH value or adding complementary chains, thereby achieving dynamic size changes of this structure.
[0023] For the DNA origami nanostructure containing the i-motif, the pH value is adjusted accordingly from 5 to 7.5 when it is extended to the double-stranded DNA, and is adjusted back to 5 when the i-motif is formed, thus achieving the adjustment of the telescopic structure.
[0024] Specifically, at pH = 5, the single-layer DNA origami structure is in a contracted state, and when the pH is adjusted to 7.5, all i-motif quadruplexes are opened, occupying a considerable space and generating a larger spacing between the helices.
[0025] For the structure replaced by the hairpin trigger unit, the hairpin is opened by adding the complementary strand of the hairpin sequence to reach the extended state, and the addition of the fuel strand F' can remove the F strand, causing the structure to reverse to the contracted state.
[0026] As a further improvement of the present invention, in S1, the volume ratio of the backbone chain to the staple chain is 1:2, the amount of substance ratio is 1:10, and the PCR program for structure assembly is: 1. 65.0°C, 15 min; 2. 65.0°C to 20°C, -0.2°C / 25s; 3. 8.0°C forever.
[0027] As a further improvement of the present invention, in S2, PEG purification was used, and an equal amount of DNA purification solution prepared by PEG-8000 was added to the single-layer DNA origami solution of S1, and the supernatant was removed by centrifugation. 1×TAE, 10mM Mg were added to the purified precipitate. 2+ The solution was mixed in a mixer, and the sample was taken out after 12 hours to detect the sample concentration.
[0028] As a further improvement of the present invention, in S2, centrifugation is performed at a setting of 35 min and 13500 rad / s.
[0029] As a further improvement of the present invention, in S2, mixing is performed in a mixer at 25°C and 800 rap.
[0030] As a further improvement of the present invention, in S3, the added stretchable complementary chains F are R-a35, B-a35, and G-a35, and the concentration of the stretchable complementary chains is 10 times the concentration of the sample.
[0031] The nucleotide sequences of R-a35, B-a35 and G-a35 are respectively:
[0032] R-a35:AGCGACCGTAAAAAAAAACGGTCGCAAAAAAAAAA (SEQ ID NO.3)
[0033] G-a35: AGCYCCTGCAAAAGAAAGCAGGAGCAAAAAAAAAA (SEQ ID NO.4)
[0034] B-a35:AGCGTCTGAAAACAAAATCAGACGCAAAAAAAAAA (SEQ ID NO.5)
[0035] As a further improvement of the present invention, in S3, the PCR program for structure assembly is: 1. 55.0°C, 5 min; 2. 55.0°C to 25°C, -0.1°C / 20s; 3. 8.0°C forever; to perform complementary stretching of the structure.
[0036] As a further improvement of the present invention, in S4, the fuel chain F' is R-b35, B-b35, G-b35, and its nucleotide sequence is completely complementary to the telescopic complementary chain F;
[0037] The nucleotide sequences of R-b35, B-b35 and G-b35 are respectively:
[0038] R-b35TTTTTTTTTGCGACCGTTTTTTTTTACGGTCGCT;
[0039] G-b35 TTTTTTTTTTGCTCCTGCTTTCTTTTGCAGGAGCT;
[0040] B-b35 TTTTTTTTTTGCGTCTGATTTTGTTTTCAGACGCT;
[0041] The concentration of the added fuel chain F' was 1 μM, and the reaction procedure was: 1. 55.0°C, 5 min; 2. 55.0°C to 25°C, -0.1°C / 20 s; 3. 8.0°C forever.
[0042] In a third aspect, the present invention provides the use of the DNA origami structure prepared by the size-adaptive delivery vector based on the DNA origami structure described in the first aspect or the method for preparing the size-adaptive delivery vector based on the DNA origami structure described in the second aspect in nanodrug delivery.
[0043] Compared with the prior art, the present invention has the following beneficial effects:
[0044] The present invention provides a design strategy for a stimulus-induced shrinkable and stretchable DNA nano-delivery system, which adjusts the spacing between the DNA double helices by changing the pH value or adding complementary chains, thereby achieving dynamic size changes of this structure, which can potentially improve the retention and permeability of nanocarriers during delivery, that is, shrinkable small carriers with targeting molecules and drug payloads can be delivered to the tumor area and their size can be expanded to minimize the elimination rate, thereby promoting the therapeutic effect. BRIEF DESCRIPTION OF THE DRAWINGS
[0045] The accompanying drawings in the specification, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.
[0046] Figure 1 This is a structural design diagram of embodiment (1).
[0047] Figure 2 Figure 3 Characterization of size-switchable DNA origami nanostructures. (a) Agarose gel electrophoresis to characterize the extension and contraction structures enabled by the i-motif. (b) Atomic force microscopy (AFM) characterization shows that the structure of the normal crossover is 50.1 nm, while the contracted i-motif cross section is 68.7 nm. (c) Atomic force microscopy (AFM) characterization shows that after the C-quadruplex is extended to a duplex, the structure extends to 151.3 nm. (d) Agarose gel electrophoresis to characterize the extension and contraction of the structure triggered by the hairpin structure. (e) Atomic force microscopy (AFM) characterization shows that the width of the structure without triggering unit replacement is 50.8 nm, while the width of the contracted hairpin structure is 67.7 nm. (f) Atomic force microscopy (AFM) characterization shows that after opening the hairpin structure, the fully extended structure reaches 150.9 nm.
[0048] Figure 3 Figure 4. Fluorescence resonance energy transfer (FRET) on expandable DNA origami nanostructures. (a) Schematic diagram of expandable monolayer DNA origami labeled with fluorescent molecules; (b) Schematic diagram of FRET effect; (c) Fluorescence emission spectrum of DNA structure, the response unit is i-motif, 1-6 is the number of structural responses, 32HB is the contracted state of the structure, and F-32HB is the extended state of the structure; (d) Fluorescence emission spectrum of nanostructure transformation with DNA hairpin as the response unit; (e) Comparison of fluorescence intensity of 6 cycle signals at a wavelength of 665nm.
[0049] Figure 4 (a) Schematic diagram of surface-modified biotin (yellow)-streptavidin (orange) on 32HB for assembling proteins with dynamic spacing on expandable DNA origami nanostructures; (b) atomic force microscopy (AFM) characterization of streptavidin coupled to biotin molecules on 32HB in the contracted state; (c) AFM characterization of streptavidin coupled to biotin molecules on 32HB in the extended state. DETAILED DESCRIPTION
[0050] It should be noted that the following detailed descriptions are all illustrative and intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.
[0051] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit exemplary embodiments according to the present invention. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprising" and / or "including" are used in this specification, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.
[0052] As introduced in the background technology, large-sized nanoparticles tend to be distributed around tumor blood vessels rather than penetrate into the tumor substance, while smaller-sized nanoparticles can penetrate deeply, but have low tumor retention, i.e., limited permeability and retention. In order to solve the above technical problems, the present invention proposes a size-adaptive delivery carrier design based on DNA origami structure.
[0053] Terminology explanation:
[0054] The backbone strand, staple strand, telescopic complementary strand, and fuel strand referred to in the present invention refer to single-stranded DNA strands with corresponding sequences.
[0055] The stapler chain of the trigger unit sequence refers to a DNA chain in which the hairpin sequence GCGACCGTTTTTTTTTACGGTCGC, GCTCCTGCTTTCTTTTGCAGGAGC, GCGTCTGATTTTGTTTTCAGACGC or the i-motif sequence is inserted into the stapler chain connecting adjacent double helices.
[0056] In the following examples, the mini-M13 scaffold DNA is a single-stranded, circular viral DNA isolated from M13mp18, containing a total of 7249 bases (p7249), and is a M13 lac phage vector purchased from Takara Biotech, product number 3518, M13mp18 Single Strand DNA (Virion DNA).
[0057] Example 1 Preparation of a DNA origami structure with switchable size through dynamic crossover
[0058] Structural assembly
[0059] The required 146 short chains (including the staple chains of the trigger unit sequence) were mixed evenly, and H2O was added to prepare 100 μL of staple, and 50 μL of backbone chain DNAp7249 (scaffold) was added at a mass ratio of 10:1 of stple: scaffold, and the total volume was adjusted to 400 μL, 1×TAE, 10 mM Mg 2+The solution was annealed at a temperature ramp of 65°C-25°C for 2 hours (1, 65.0°C, 15 min; 2, 65.0°C to 20°C, -0.2°C / 25 s; 3, 8.0°C forever) for structural assembly.
[0060] Structural purification
[0061] Using PEG purification, add an equal amount of DNA purification solution prepared by PEG-8000 to 400 μL, centrifuge at 35 min and 13500 rad / s to obtain purified precipitate, then add 200 μL 1×TAE, 10 mM Mg 2+ Put the solution into a mixer at 25°C and 800 rap, mix for 12 hours, and then take out the sample to test the concentration.
[0062] DNA structure stretching
[0063] To open the hairpin or i-motif, complementary strand F (R-a35, B-a35, G-a35) was added and annealed at 55°C to 25°C for 2 hours (1, 55.0°C, 5min; 2, 55.0°C to 25°C, -0.1°C / 20s; 3, 8.0°C forever) to achieve DNA origami structure extension. The addition of fuel strand F' (R-b35TTTTTTTTTTGCGACCGTTTTTTTTTACGGTCGCT; G-b35TTTTTTTTTTGCTCCTGCTTTCTTTTGCAGGAGCT; B-b35TTTTTTTTTTGCGTCTGATTTTGTTTTCAGACGCT) removed the complementary strand and drove the structure to the contracted state. For the DNA origami nanostructure containing i-motif, the pH value was adjusted from 5 to 7.5 when extending to double-stranded DNA and back to 5 when i-motif was formed.
[0064] Example 2 Assembly of four other groups of biotin-modified DNA chains
[0065] The method for assembling a DNA origami structure is the same as in Example 1, and the stapler chain is designed to be a biotin-modified DNA chain to obtain an assembly of a biotin-modified DNA origami structure.
[0066] Spacing is critical for regulating multienzyme cascade reactions, and contraction and extension allow the construction of functional arrays with dynamic spacing. As a proof-of-concept, biotin-modified DNA strands were assembled at selected positions on 32HB consisting of hairpin crossovers, demonstrating changes in avidin-avidin distances and structural scalability ( Figure 4 a). AFM image confirms the assembled avidin on the biotin sites, with a spacing of approximately 15.8 nm ( Figure 4 b, c), and the distance between them expands to about 27.5 nm due to structural expansion. This demonstrates the ability to facilitate programmed dynamic assembly and study complex molecular interactions at the nanoscale.
[0067] Example 3 Performance Test
[0068] (1) Verify the dimensional switchability of the structure
[0069] Agarose gel electrophoresis and atomic force microscopy (AFM) to verify DNA nanostructures
[0070] Agarose gel electrophoresis and atomic force microscopy (AFM) were used to verify the folding of DNA nanostructures and their size switchability. Figure 2 ). Figure 2 a shows an image of 32HB containing i-motif replacement by agarose gel electrophoresis (1%, 65V, 1x triacetic acid-ethylenediaminetetraacetic acid buffer, 2 hours). The static origami structure 16HB was set as the control. The gel band shows that at pH = 5, the contracted 32HB has a mobility similar to that of the control structure. But when all the i-motif quadruplexes are opened, the migration of the extended structure is delayed compared to the control, indicating that the structure is larger and more difficult to migrate at pH = 7.5. AFM characterization verified the size difference. At pH = 5, 32HB showed that the width of the statically controlled 16HB was about 50.1nm, and the width of the remaining i-motif replaced structures was about 68.7nm ( Figure 2 b). Through testing, it can be believed that the i-motif quadruplex connection point occupies a considerable space and produces a larger spacing between the helices. Under pH = 7.5, after the i-motif is opened in a complementary chain manner, the length of the extended structure is about 151.3nm, which is more than twice as large as the original one ( Figure 2 c). For the structure with hairpin trigger unit replacement, the hairpin is opened by adding the complementary chain of the hairpin sequence to achieve the extended state. The addition of fuel chain F' can remove the F chain and reverse the structure to the contracted state. Agarose gel electrophoresis showed that the contraction and extension of 16HB resulted in different mobilities of 32HB. Although the difference in mobility is subtle, it reflects the difference in size. AFM images further demonstrate the switchability of size. The measured length of static 16HB is about 50.8nm, and the 16HB containing the hairpin replacement Holiday junction is about 67.7nm in the contracted state, which is 17nm larger than the static control ( Figure 2e). Similarly, it can be considered that the secondary structure using the hairpin sequence as a joint occupies a part of the space, which causes a size difference compared with the structure made using the traditional Holiday junction, so the size of both structures in the contracted state is greater than the calculated value. For the extended structure of the two replaced Holiday junctions, due to the fully opened hairpin or i-unit structure, it presents a grid-like structure, verifying that the redesign of the Holiday junction (i.e., inserting a dynamic trigger unit sequence) can expand the single-layer origami structure by more than 2 times.
[0071] Fluorescence resonance energy transfer on scalable DNA origami nanostructures
[0072] FRET (fluorescence resonance energy transfer) dye pairs are labeled on adjacent DNA double helices to study reversible structural changes. Specifically, when the structure is in a contracted state, energy is transferred from Cy3 to Cy5, the emission intensity of the donor dye decreases, and the emission intensity of the acceptor dye increases. When the structure is extended and the distance between the two dyes exceeds the FRET distance, energy transfer is inhibited ( Figure 3 a). Under 547 nm excitation, the emission spectrum of Cy5 was collected and the effect of the stretching and contraction of 32HB on the luminescence intensity of the acceptor dye was investigated. Figure 3 c shows the fluorescence spectrum of Cy5 on 32HB containing i-motif substitution. Figure 3 When 32HB-1,3 in c is in a contracted state, the emission intensity of Cy5 indicates that its energy transfer efficiency is high. Figure 3 F-32HB-2,4 in c), FRET is blocked and the Cy5 fluorescence intensity decreases. The i-motif achieves a reversible size change, achieving an alternating FRET signal change from Cy3 to Cy5. However, signal damping due to side reactions and fuel chain accumulation can also be seen. A similar trend is also seen for 32HB containing a hairpin structure substitution. The opened hairpin structure extends the structure, blocking the energy transfer from Cy3 to Cy5. By comparing the maximum emission of the two nanostructures at 665nm ( Figure 3 e), the structure containing the i-motif substitution shows a more pronounced signal change, but also decreases more rapidly than the structure with the hairpin sequence substitution. The reversible opening and folding of the i-motif quadruplex requires buffer exchange, which involves multiple rounds of centrifugation, causing structural damage and sample loss. Nevertheless, FRET measurements support this redesign of the Holiday junction to enable size-switchability.
[0073] (2) Verify that the structure contracts and stretches with a dynamically spaced functional array
[0074] Spacers are essential for regulating multienzyme cascade reactions, and contraction and extension allow the construction of functional arrays with dynamic spacers. For practical applications, four sets of biotin-modified DNA strands were assembled at selected positions on 32HB prepared from hairpin dynamic units, and the variation of avidin-avidin distance with structural expandability was achieved ( Figure 4 a). AFM images confirm that the spacing between avidin fixed on the DNA carrier by biotin is about 15.8nm ( Figure 4 b,c), and due to the structural stretching, the distance between the avidins expanded to about 27.5nm. This demonstrates the ability to promote programmed dynamic assembly and study complex molecular interactions at the nanoscale.
[0075] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A size-adaptive delivery vector based on DNA origami structure, It is characterized in that The invention comprises a single-layer DNA origami structure, which is divided into a dynamic unit and a static control unit. The dynamic unit scaffold DNA is wired in a zigzag manner, and adjacent DNA helices are cross-linked by stapled single strands; the targeting molecule or drug molecule is connected to the DNA and is complementary grafted to the DNA nanostructure carrier to realize nano drug delivery.
2. The size-adaptive delivery vector based on DNA origami structure as claimed in claim 1, It is characterized in that There are 5 or 6 sites where the staple chain connects each adjacent spiral. The self-complementary sequences of the staple chain are 25-nt i-motif and DNA hairpin molecules. The 25-nt i-motif nucleotide sequence is shown in SEQ ID NO.1, and the DNA hairpin nucleotide sequence is shown in SEQ ID NO.
2.
3. The size-adaptive delivery vector based on DNA origami structure as claimed in claim 1, It is characterized in that The single-layer DNA origami body is composed of 32 double helices, all the Holiday cross-connection units in the upper 16HB are replaced by dynamic DNA units, and the Holiday cross design is retained in the lower 16HB as a static control unit.
4. The size-adaptive delivery vector based on DNA origami structure as claimed in claim 1, It is characterized in that The main body width of the single-layer DNA origami structure is 51 nm, and the length size range of the dynamic unit is 40.5 nm to 157.5 nm.
5. A method for preparing a size-adaptive delivery vector based on DNA origami structure, It is characterized in that The steps include: S1: Preparation of single-layer DNA origami; S2: Purification of the monolayer DNA origami in S1; S3: Assemble the telescopic complementary chain F with the sample in S2 to achieve the extension of the DNA origami structure; S4: Add fuel chain F' to replace the telescopic complementary chain F to achieve the contraction of the DNA origami structure.
6. The preparation method according to claim 5, It is characterized in that In S1, the backbone chain and the staple chain were mixed evenly in 1×TAE, 10mMMg 2+ An annealing reaction is carried out in a solution to obtain a single-layer DNA origami solution; the backbone chain is a mini-M13 scaffold DNA; and the staple chain contains a 25-nt i-motif and a DNA hairpin sequence.
7. The preparation method according to claim 6, It is characterized in that The volume ratio of the skeleton chain to the staple chain is 1:2, and the amount of substance ratio is 1:
10.
8. The preparation method according to claim 5, It is characterized in that In S2, PEG purification was used to add an equal amount of DNA purification solution prepared by PEG-8000 to the S1 single-layer DNA origami solution. After centrifugation to obtain the purified precipitate, 1×TAE, 10 mM Mg 2+ The solution was mixed in a mixer, and the sample was taken out after 12 hours to detect the sample concentration.
9. The preparation method according to claim 5, It is characterized in that In S3, the concentration of the stretching complementary chain F was 10 times the sample concentration; in S4, the concentration of the added fuel chain F' was 1 μM.
10. Use of a DNA origami structure prepared by the size-adaptive delivery vector based on a DNA origami structure as described in claims 1-4 or the method for preparing the size-adaptive delivery vector based on a DNA origami structure as described in claims 5-9 in nanodrug delivery.
Citation Information
Cited By
Targeted protein degradation robot based on DNA origami and construction method and application thereof
CN121910890A
